RAMAZZOTTI DANIELE

Ilari, A., Cogliati, V., Sherif, N., Grassilli, E., Ramazzotti, D., Cordani, N., et al. (2024). Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer. BIOMEDICINES, 12(2) [10.3390/biomedicines12020272]. Detail

Crippa, V., Fina, E., Ramazzotti, D., Piazza, R. (2024). Control-FREEC viewer: a tool for the visualization and exploration of copy number variation data. BMC BIOINFORMATICS, 25(1) [10.1186/s12859-024-05694-w]. Detail

Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Detail

Elli, E., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., et al. (2024). Idiopathic erythrocytosis: a germline disease?. CLINICAL AND EXPERIMENTAL MEDICINE, 24(1) [10.1007/s10238-023-01283-y]. Detail

Chen, B., Ramazzotti, D., Heide, T., Spiteri, I., Fernandez-Mateos, J., James, C., et al. (2023). Contribution of pks+ E. coli mutations to colorectal carcinogenesis. NATURE COMMUNICATIONS, 14(1) [10.1038/s41467-023-43329-5]. Detail